Company Encyclopedia
View More
name
Abivax SA
ABVX.US
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France.
1.912 T
ABVX.USMarket value -Rank by Market Cap -/-

Financial Score

22/12/2025 Update
D
BiotechnologyIndustry
Industry Ranking194/400
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.00%D
    • Profit Margin-5526.64%E
    • Gross Margin100.00%A
  • Growth ScoreE
    • Revenue YoY-41.62%E
    • Net Profit YoY-62.41%D
    • Total Assets YoY0.00%C
    • Net Assets YoY0.00%C
  • Cash ScoreD
    • Cash Flow Margin-1.81%D
    • OCF YoY-41.62%E
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreA
    • Gearing Ratio21.60%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Market Chatter: Eli Lilly Meets With French Officials Over Possible Acquisition of Abivax; Shares Up Pre-Bell

    Eli Lilly is in early discussions with French authorities about potentially acquiring biotech firm Abivax. Preliminary talks were held with France's Treasury to assess the takeover under foreign investment rules. The involvement of state-backed investor Bpifrance as a minority shareholder was also discussed. Abivax shares rose 14% premarket, while Lilly shares increased by 0.1%.

    fidelity·
    US
    LLY
    +1.38%
    US
    ABVX
    +1.17%
    fidelity·
    US
    LLY
    +1.38%
    US
    ABVX
    +1.17%

    European shares slip as investors navigate Holiday-shortened week

    European shares slightly declined as the STOXX 600 fell 0.1% amid a holiday-shortened week. Technology and commodity stocks saw gains, while consumer staples and the defense sector retreated. Abivax surged 7.6% on Eli Lilly takeover rumors, while Telecom Italia dropped 5% due to share conversion plans. Analysts expect market volatility due to low liquidity, with positive macroeconomic momentum anticipated in the Eurozone.

    Reuters·
    US
    ABVX
    +1.17%
    US
    TGT
    -1.05%
    US
    COST
    -0.23%
    Reuters·
    US
    ABVX
    +1.17%
    US
    TGT
    -1.05%
    US
    COST
    -0.23%

    BUZZ-Abivax jumps on media reports of Eli Lilly takeover bid

    BUZZ-Abivax jumps on media reports of Eli Lilly takeover bid

    Reuters·
    US
    LLY
    +1.38%
    Reuters·
    US
    LLY
    +1.38%

    European shares steady after record close entering holiday week

    European shares held steady on Monday after a record-high close, with tech and commodity-linked stocks providing support. The STOXX 600 was at 587.28, with major regional markets in London and France down 0.3%. Tech shares gained 0.6%, and commodity-linked sectors traded higher. Abivax jumped 10% on takeover rumors by Eli Lilly.

    Reuters·
    US
    ABVX
    +1.17%
    US
    LLY
    +1.38%
    Reuters·
    US
    ABVX
    +1.17%
    US
    LLY
    +1.38%

    Abivax SA Joins Nasdaq Biotechnology Index

    Abivax SA will be added to the Nasdaq Biotechnology Index on December 22, 2025, reflecting its progress in advancing obefazimod through successful Phase 3 trials for ulcerative colitis and increased visibility in the global biotechnology community.

    Reuters·
    US
    ABVX
    +1.17%
    Reuters·
    US
    ABVX
    +1.17%
    Posts
    View More

    Hello stock fans some names moving higher in premarket $Photronics(PLAB.US) $Horizon Space Acquisition I(HSPO.US) $Braze(BRZE.US) $GE Vernova LLC(GEV.US) $Abivax SA(ABVX.US) $AKT $Jumia Tech AG (JMIA...........................

    © 2025 Longbridge｜Disclaimer